Evidence map›Paper›PMID 33141307›Full record

ArticleOdontology2021

Anti-inflammatory effect of glycyrrhizin with Equisetum arvense extract.

Fumie Shiba, Mutsumi Miyauchi, Chanbora Chea, Hisako Furusho, Saori Iwasaki, Rika Shimizu, Kouji Ohta, Tatsuji Nishihara, Takashi Takata

Abstract read
PubMed Publisher
In one paragraph

Article in Odontology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Phytochemical Investigation ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Host mRNA Analysis of Periodontal Disease Patients Positive forInternational journal of molecular sciences · 2022
    Review
  9. International journal of dentistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Fumie ShibaResearch and Development Headquarters, Earth Corporation, Ltd., Hyogo, 678-0192, Japan.
Mutsumi MiyauchiDepartment of Oral and Maxillofacial Pathobiology, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan. mmiya@hiroshima-u.ac.jp.
Chanbora CheaDepartment of Oral and Maxillofacial Pathobiology, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.
Hisako FurushoDepartment of Oral and Maxillofacial Pathobiology, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.
Saori IwasakiResearch and Development Headquarters, Earth Corporation, Ltd., Hyogo, 678-0192, Japan.
Rika ShimizuResearch and Development Headquarters, Earth Corporation, Ltd., Hyogo, 678-0192, Japan.
Kouji OhtaDepartment of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8553, Japan.
Tatsuji NishiharaDivision of Infections and Molecular Biology, Department of Health Promotion, Kyushu Dental University, Kitakyushu, 803-8580, Japan.
Takashi TakataDepartment of Oral and Maxillofacial Pathobiology, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.
Hiroshima University · JPKyushu Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periodontal disease is the most prevalent infectious disease, and inflammatory mediators play critical roles in its progression. Therefore, controlling pro-inflammatory cytokine production, especially at initial disease stages, is essential to maintaining gingival and periodontal health. Glycyrrhizin (GL) has an anti-inflammatory effect and has been added to toothpaste and mouth rinse to prevent periodontal disease. However, there is a maximum dose for the use of GL. The aim of the present study is to screen plant extracts which can effectively enhance the effects of GL. The effects of extracts from six different plants on GL-suppressed TNF-α expression in Aggregatibacter actinomycetemcomitans (A.a.)-LPS-stimulated human oral keratinocytes (RT7) were examined. Results demonstrated that Equisetum arvense (EA) extract had the strongest additive effect on the suppression of TNF-α by GL at both mRNA and protein levels. In addition, GL downregulated the production of TNF-α by suppressing NF-κB p65 phosphorylation, but not JNK or p38 phosphorylation. In contrast, EA decreased JNK phosphorylation but not NF-κB p65 or p38 phosphorylation. The combination of GL and EA effectively attenuated A.a.-LPS-induced phosphorylation of NF-κB p65 and JNK. Furthermore, an LPS-induced periodontitis rat model showed that GL with EA supplementation significantly downregulated TNF-α mRNA in the gingival tissue. These results indicate that EA can suppress A.a.-LPS-induced pro-inflammatory cytokine production by inhibiting JNK activation and can promote the anti-inflammatory effects of GL. Our findings suggest that a combination of GL and EA may improve the development of new oral hygiene products aimed at enhancing periodontal health.

Indexed as

EquisetumGlycyrrhizic AcidAnimalsAnti-Inflammatory AgentsInflammationLipopolysaccharidesNF-kappa BPlant ExtractsRatsAnti-Inflammatory AgentsGlycyrrhizic AcidLipopolysaccharidesNF-kappa BPlant ExtractsEquisetum arvenseGingivaGlycyrrhizinInflammationJunctional epitheliumPeriodontitis

Identifiers

PMID33141307
OpenAlexW3095938699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.